Literature DB >> 2985028

Membrane-bound virions of coxsackievirus B4: cellular localization, analysis of the genomic RNA, genome-linked protein, and effect on host macromolecular synthesis.

N K Chatterjee, C Nejman.   

Abstract

Hela cells infected with several group B coxsackieviruses contain, in addition to standard virions, a population of virus-specific ribonucleoprotein particles which we (5) designated membrane-bound virions (MBV). MBVs differ from standard virions in buoyant density, yield, appearance, protein composition and infectivity. Here we present several new features of MBVs of coxsackievirus B4. The MBVs are lighter (rho about 1.30) and are localized in rough membranes, intermixed with virions. They contain 35S virion RNA covalently linked with a small protein, VPg. The VPg contain two proteins of different charge. MBV VPg is considerably smaller than the 5300-dalton virion VPg. MBV RNA is homologous to the base sequence present in B4 virus double-stranded RNA. The T1 oligonucleotide fingerprint of MBV RNA is distinguishable from that of virion RNA by one oligonucleotide. Several oligonucleotides of virion RNA appear to occur in submolar quantities in MBV RNA. MBVs are 75 to greater than 200 times less infective; they inhibit host cell macromolecular synthesis less efficiently than virions. In coinfected cells, the extent of inhibition of host synthesis is less severe than in cells infected with virions alone, which suggest interference by MBV particles.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985028     DOI: 10.1007/bf01310557

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  23 in total

1.  Defective interfering particles of poliovirus: mapping of the deletion and evidence that the deletions in the genomes of DI(1), (2) and (3) are located in the same region.

Authors:  A Nomoto; A Jacobson; Y F Lee; J Dunn; E Wimmer
Journal:  J Mol Biol       Date:  1979-02-25       Impact factor: 5.469

2.  The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg.

Authors:  A Nomoto; N Kitamura; F Golini; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

3.  The role of cytoplasmic membranes in poliovirus biosynthesis.

Authors:  L A Caliguiri; I Tamm
Journal:  Virology       Date:  1970-09       Impact factor: 3.616

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Translation of coxsackievirus B RNAs in a rabbit reticulocyte lysate: characterization of the genome RNA, reaction conditions for translation, and analysis of the products.

Authors:  N K Chatterjee; C Tuchowski
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

6.  Comparison of capsid polypeptides of group B coxsackie-viruses and polypeptide synthesis in infected cells.

Authors:  N K Chatterjee; C Tuchowski
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

Review 7.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

8.  Isolation and characterization of a membrane-bound population of group B coxsackieviruses.

Authors:  N K Chatterjee; W A Samsonoff; C Tuchowski
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

9.  Heterogeneity of the genome-linked protein of foot-and-mouth disease virus.

Authors:  A M King; D V Sangar; T J Harris; F Brown
Journal:  J Virol       Date:  1980-06       Impact factor: 5.103

Review 10.  Picornaviral structure and assembly.

Authors:  J R Putnak; B A Phillips
Journal:  Microbiol Rev       Date:  1981-06
View more
  1 in total

1.  Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis.

Authors:  P E Tam; A M Schmidt; S R Ytterberg; R P Messner
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.